Latest filing published 13 Aug 2026 for Dexcom Inc.
Nicholas Augustinos reported 50 transactions at Dexcom Inc, a Nasdaq company where the listed title is Director, from May 26, 2016 to August 13, 2026. The record holds 25 sales, worth EUR 7,473,261, with a median of EUR 206,721. No purchase appears.
The largest, EUR 1,283,924, dates from October 29, 2021. Then come EUR 638,129 on August 6, 2018 and EUR 636,782 on February 16, 2021. The rest of the record consists of 12 share grants and 13 filings of another kind.
The peak is 2020, with 14 filings, when most years count between 1 and 7. Two filings fall in the last twelve months, with neither a sale nor a purchase. Publication takes a median of 3 days. Within 30 days of colleagues at Dexcom Inc, Augustinos has 23 and 21 own market trades, in that order. All in the same direction. Colleagues in order: Steven Robert Pacelli and Kevin R. Sayer.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 50 declarations